Geographic Access to Medication Assisted Treatment for Medicaid Enrollees with Opioid Use Disorder
PI: Coleman Drake, PhD
Funding Sources: NIH/NIDA, March 2020 - August 2022
National Center for Advancing Translational Sciences, June 2019 - May 2021
Limited geographic access to Medication Assisted Treatment (MAT) is a key barrier to Opioid Use Disorder (OUD) treatment because MAT requires frequent travel to providers. This proposal will determine where and for whom geographic access to MAT is limited, and it will examine how geographic access to MAT affects OUD-related health outcomes. Improved measurement of geographic access to MAT will enable policymakers to implement targeted, effective interventions to increase MAT access and use.
Read published results from this work
From: Geographic access to buprenorphine prescribers for patients who use public transit, Journal of Substance Abuse Treatment, October 2020